advertisement
11.14 Investigational drugs; pharmacological experiments (97)
Showing records 1 to 25
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments76938 Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
Impagnatiello F
British Journal of Pharmacology 2019; 176: 1079-1089
76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Gu L
Neuroscience Letters 2018; 670: 89-93
76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
Kazemi A
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386
77101 Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Hoy SM
Drugs 2018; 78: 773-780
76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Zhang QL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500
76694 Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats
Hampel U
International Ophthalmology 2019; 39: 847-851
76503 Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma
Honjo M
Japanese Journal of Ophthalmology 2018; 62: 109-126
76816 Neuroprotective Effects of Psalmotoxin-1, an Acid-Sensing Ion Channel (ASIC) Inhibitor, in Ischemia Reperfusion in Mouse Eyes
Dibas A
Current Eye Research 2018; 43: 921-933
77039 The nitric oxide-guanylate cyclase pathway and glaucoma
Wareham LK
Nitric oxide : biology and chemistry 2018; 77: 75-87
76551 Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma
Kusuhara S
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 809-814
76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Prasanna G
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716
77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Stacy R
American Journal of Ophthalmology 2018; 192: 113-123
77175 Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil
Inoue K
Japanese Journal of Ophthalmology 2018; 62: 508-516
76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Stack T
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779
77159 Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
Miller S
Pharmaceuticals (Basel, Switzerland) 2018; 11:
77184 A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
Stacy R
American Journal of Ophthalmology 2018; 192: 113-123
76553 The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans
McLaren JW
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 380-386
76694 Relaxin 2 fails to lower intraocular pressure and to dilate retinal vessels in rats
Träger K
International Ophthalmology 2019; 39: 847-851
76503 Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma
Tanihara H
Japanese Journal of Ophthalmology 2018; 62: 109-126
76619 GRGM-13 comprising 13 plant and animal products, inhibited oxidative stress induced apoptosis in retinal ganglion cells by inhibiting P2RX7/p38 MAPK signaling pathway
Wang W
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018; 101: 494-500
76551 Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma
Katsuyama A
Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256: 809-814
76552 Modulation of Schlemm's canal endothelial cell stiffness via latrunculin loaded block copolymer micelles
Vahabikashi A
Journal of Biomedical Materials Research - Part A 2018; 106: 1771-1779
77175 Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil
Ishida K
Japanese Journal of Ophthalmology 2018; 62: 508-516
76424 The effect of celastrol on the ocular hypertension-induced degeneration of retinal ganglion cells
Kwong JMK
Neuroscience Letters 2018; 670: 89-93
76843 A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing
Ferrara L
Investigative Ophthalmology and Visual Science 2018; 59: 1704-1716
